DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort

Genes (Basel). 2023 Dec 19;15(1):3. doi: 10.3390/genes15010003.

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a late-onset cilia-related disorder, characterized by progressive cystic enlargement of the kidneys. It is genetically heterogeneous with PKD1 and PKD2 pathogenic variants identified in approximately 78% and 15% of families, respectively. More recently, additional ADPKD genes, such as DNAJB11, have been identified and included in the diagnostic routine test for renal cystic diseases. However, despite recent progress in ADPKD molecular approach, approximately ~7% of ADPKD-affected families remain genetically unresolved. We collected a cohort of 4 families from our center, harboring heterozygous variants in the DNAJB11 gene along with clinical and imaging findings consistent with previously reported features in DNAJB11 mutated patients. Mutations were identified as likely pathogenetic (LP) in three families and as variants of uncertain significance (VUS) in the remaining one. One patient underwent to kidney biopsy and showed a prevalence of interstitial fibrosis that could be observed in ~60% of the sample. The presence in the four families from our cohort of ADPKD characteristics together with ADTKD features, such as hyperuricemia, diabetes, and chronic interstitial fibrosis, supports the definition of DNAJB11 phenotype as an overlap disease between these two entities, as originally suggested by the literature.

Keywords: ADPKD; DNAJB11; atypical; genetics; mutation.

MeSH terms

  • Fibrosis
  • HSP40 Heat-Shock Proteins / genetics
  • Humans
  • Kidney
  • Mutation
  • Polycystic Kidney, Autosomal Dominant* / diagnosis
  • Polycystic Kidney, Autosomal Dominant* / genetics
  • TRPP Cation Channels / genetics

Substances

  • TRPP Cation Channels
  • DNAJB11 protein, human
  • HSP40 Heat-Shock Proteins

Grants and funding

This research received no external funding.